References
- Albarellos G., Montoya L., Ambros L., Kreil V., Hallu R., Rebuelto M. Multiple once‐daily dose pharmacokinetics and renal safety of gentamicin in dogs. J. Vet. Pharmacol. Ther. 2004; 27: 21–25
- Allen D. G., Pringle J. K., Smith D. A., Pasloske K. Common dosages for dogs and cats. Handbook of Veterinary Drugs2nd Ed. Lippincott‐Raven, Philadelphia 1998; 5–51
- Bajcsy C. A., Reiczigel J., Szenci O. Circadian changes in blood ionized calcium, sodium, potassium and chloride concentrations and pH in cattle. Am. J. Vet. Res. 1999; 60: 945–948
- Batra V. K., Morrison J. A., Hoffman T. R. Pharmacokinetics of piperacillin and gentamicin following intravenous administration to dogs. J. Pharm. Sci. 1983; 72: 894–897
- Beauchamp D., Guimont C., Grenier L., LeBrun M., Tardif D., Gourde P., Bergeron M. G., Thibault L., Labrecque G. Time‐restricted feeding schedules modify temporal variation of gentamicin experimental nephrotoxicity. Antimicrob. Agents Chemother. 1997; 41: 1468–1474
- Behrend E. N., Grauer G. F., Greco D. S., Fettman M. J., Allen T. A. Effects of dietary protein conditioning on gentamicin pharmacokinetics in dogs. J. Vet. Pharmacol. Ther. 1994; 17: 259–265
- Bennet J. V., Brodie J. L., Benner E. J., Kirby W. M.M. Simplified, accurate method for antibiotic assay of clinical specimens. Appl. Microbiol. 1966; 14: 170–177
- Bleyzac N., Allard‐Latour B., Laffont A., Mouret J., Jelliffe R., Maire P. Diurnal changes in the pharmacokinetic behavior of amikacin. Ther. Drug Monit. 2000; 22: 307–312
- Boggio J. C., Valtorta E. S., Sánchez S., McKellar Q. Chronobiological variations of indomethacin pharmacokinetic parameters in sheep. J. Vet. Pharmacol. Ther. 2001; 24: 261–265
- Craig W. A. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin. Infect. Dis. 1998; 26: 1–12
- Drusano G. L. Antimicrobial pharmacodynamics: critical interactions of “bug and drug.”. Nat. Rev. Microbiol. 2004; 2: 289–300
- Fisch J. E., Yonovitz A., Smolensky M. H. Effects of circadian rhythm on kanamycin‐induced hearing loss. Ann. Rev. Chronopharmacol. 1984; 1: 385–388
- Gibaldi M., Perrier D. Farmacocinética. Editorial Reverté, S.A., BarcelonaSpain 1982; 182–184
- Guisson P., Guisinard G., Legheand J., Sassard J. Chronopharmacokinetics of indomethacin in rats. Artznein‐Forsch. Drug Res. 1987; 37 II: 1034–1037
- Jori A., Di Salle E., Santini V. Daily rhythmic variation and liver drug metabolism in rats. Biochemical Pharmacol. 1971; 20: 2965–2969
- Lin L., Grenier L., Bergeron Y., Simard M., Bergeron M., Labrecque G., Beauchamp D. Temporal changes of pharmacokinetics, nephrotoxicity and subcellular distribution of tobramycin in rats. Antimicrob. Agents Chemother. 1994; 38: 54–60
- Mesnard‐Ricci B., White C. A. Chronokinetics of active biliary ampicillin secretion in rats. Chronobiol. Int. 1998; 15: 309–321
- Pariat C., Cambar J., Courtois P. Circadian variation in the acute toxicity of three aminoglycosides: gentaminin, dibekacin and netilmicin in mice. Ann. Rev. Chronopharmacol. 1984; 1: 381–384
- Pons M., Forpomés O., Espagnet S., Cambar J. Relationship between circadian changes in renal hemodynamics and circadian changes in urinary glycosaminoglycan excretion in normal rats. Chronobiol. Int. 1996a; 13: 349–358
- Pons M., Schnecko A., Witte K., Lemmer B., Waterhouse J. M., Cambar J. Circadian rhythms in renal function in hypertensive TGR mRen‐2 rats and their normotensive controls. Am. J. Physiol., 271 (Regulatory Integrative Comp. Physiol.) 1996b; 40: R1002–R1008
- Prins J. M., Weverling G. J., de Block K., van Keteel R. J., Speelman P. Validation and nephrotoxicity of a simplified once‐daily aminoglycoside dosing schedule and guidelines for monitoring therapy. Antimicrob. Agents Chemother. 1996; 40: 2494–2499
- Rackley R., Meyer M., Straughn B. Circadian rhythm in theophylline disposition during a constant rate intravenous infusion of aminophylline in the dog. J. Pharm. Sci. 1988; 77: 658–661
- Radzialowski F. M., Bousquet W. F. Daily rythmic variation in hepatic drug metabolism in the rat and mouse. J. Pharmacol. Exp. Ther. 1968; 163: 229–238
- Rebuelto M., Ambros L., Rubio M. Chronopharmacological study of an antimicrobial agent, norfloxacin, in the rat. Biological Rhythms Research 2003a; 34: 53–62
- Rebuelto M., Ambros L., Rubio M. Daily variations in ceftriaxone pharmacokinetics in rats. Antimicrob. Agents Chemother. 2003b; 47: 809–812
- Riviere J. E., Coppoc G. L., Hinsman E. J., Carlton W. W. Gentamicin pharmacokinetic changes in induced acute canine nephrotocic glomerulonephritis. Antimicrob. Agents Chemother. 1981; 20: 387–392
- Riviere J. E., Spoo J. W. Aminoglycoside antibiotics. Veterinary Pharmacology and Therapeutics8th ed, H. R. Adams. Iowa State University Press, Ames, Iowa 2001; 841–867
- Sarveshwer Rao V. V., Rambhau D., Ramesh Rao B., Srinivasu P. Circadian variation in urinary excretion of ciprofloxacin after a single‐dose oral administration at 1000 and 2200 hours in human subjects. Antimicrob. Agents Chemother. 1997; 41: 1802–1804
- Soulban G., Yonovitz A. Gentamicin‐induced chronotoxicity: use of body temperature as a circadian marker. Ann. Rev. Chronopharmacol. 1986; 3: 293–296
- Touitou Y., Portaluppi F., Smolensky M. H., Rensing L. Ethical principles and standards for the conduct of human and animal biological rhythm research. Chronobiol. Int. 2004; 21: 161–170
- White C. A., Pardue R., Huang C., Warren L. Chronobiological evaluation of the active biliary and renal secretion of ampicillin. Chronobiol. Int. 1995; 12: 410–418
- Wilson R. C., Duran S. H., Horton C. R., Wright L. C. Bioavailability of gentamicin in dogs after intramuscular or subcutaneous injections. Am. J. Vet. Res. 1989; 50: 1748–1750
- Xiong Y., Caillon J., Kergueris M. F., Drugeon H., Baron D., Potel G., Bayer S. A.S. Adaptive resistance of Pseudomonas aeruginosa induced by aminoglycosides and killing kinetics in a rabbit endocarditis model. Antimicrob. Agents Chemother. 1997; 41: 823–826
- Yamaoka K., Nakagawa T., Uno T. Application of akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J. Pharmacokinet. Biopharm. 1978; 6: 165–175
- Yoshiyama Y., Nishikawa S., Sugiyama T., Kobayashi T., Shimada H., Tomonaga F., Ohdo S., Ogawa N., Nakano S. Influence of circadian‐stage‐dependent dosing schedule on nephrotoxicity and pharmacokinetics of isepamicin in rats. Antimicrob. Agents Chemother. 1993; 37: 2042–2043